FOXO4.
FOXO4-DRI is a D-amino acid retro-inverso peptide (DRI) and p53-interaction domain analog. With the molecular formula C₂₂₈H₃₉₀N₈₆O₇₅S₂ and a molecular weight of 5358.1 g/mol (CAS: 1449830-41-4), it st...
Lab Verified
Clinical Grade
PMID Cited
Mechanism of Action.
Published preclinical research has characterized the following molecular pathways and receptor interactions for FOXO4.
FOXO4-p53 Interaction
Published research demonstrates FOXO4-DRI modulates targeted signaling cascades within cell tissue models.
Senescence-associated pathways
In cellular environments, FOXO4-DRI exhibits selective binding and corresponding pathway activation.
Clinical Literature
Research review on FOXO4 molecular characterization.
Preclinical studies have characterized the molecular properties and receptor binding profiles of FOXO4 in standardized assay systems.
FOXO4 structure-activity relationship analysis.
Structure-activity relationship studies have examined the functional domains and binding characteristics of FOXO4 in cell-free and cell-based systems.
RESEARCH USE ONLY: This compound is intended exclusively for in vitro laboratory research. Not for human or veterinary use. Not intended to diagnose, treat, cure, or prevent any disease. Not evaluated by the FDA. Must be 21+ to purchase.
Related Compounds.
GH SecretagoguesCJC no DAC
$43.00C152H252N44O42 · 3367.9 g/mol
For in vitro research use only. Not for human consumption.
GH SecretagoguesCJC/IPA
$62.00Blend · Mixed
For in vitro research use only. Not for human consumption.
GH SecretagoguesIpamorelin
$28.00C38H49N9O5 · 711.87 g/mol
For in vitro research use only. Not for human consumption.